Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Delayed Emesis and Appetite in Breast Cancer
NCT02336750Phase 3Completed
- Sponsor
- Fudan University
- Start
- Dec 2014
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mirtazapine in chemotherapy-induced nausea and vomiting (CINV) and anorexia nervosa (AN) (2 arms), sponsored by Fudan University. Primary endpoint: Delayed emesis control at 6 days. Started Dec 2014; status: completed.
02
Drugs
mirtazapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT02336750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336750.